Clinical Trial Update: Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed weekly intravenous administration of BI 836845 in Japanese patients with advanced solid tumors. The study is completed and results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• BI 836845

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2025-06-19